Common Stock	9 Months Ended
Sep. 30, 2022
Equity [Abstract]
Common Stock	Note 4 – Common Stock During the nine months ended September 30, 2022, the Company issued 1,800,000 shares of its restricted common stock at a price of $0.20 per share for working capital and to settle $40,000 of accounts payable to a company controlled by an officer of the Company. During the period ended September 30, 2021, the Company issued 29,573,848 shares of its restricted common stock with a fair value of $14,065,923 to settle $662,251 in accounts payable and accrued liabilities, $107,800 in convertible loans, $480,960 in loans payable to stockholders, $130,947 in loans payable to related party, $74,762 in loans payable, and $149,124 in amounts due to related parties. This resulted in a loss on debt settlement of $12,460,079.

Common Stock

9 Months Ended

Sep. 30, 2022

Note 4 – Common Stock

During the nine months ended September 30, 2022, the Company issued 1,800,000 shares of its restricted common stock at a price of $0.20 per share for working capital and to settle $40,000 of accounts payable to a company controlled by an officer of the Company.

During the period ended September 30, 2021, the Company issued 29,573,848 shares of its restricted common stock with a fair value of $14,065,923 to settle $662,251 in accounts payable and accrued liabilities, $107,800 in convertible loans, $480,960 in loans payable to stockholders, $130,947 in loans payable to related party, $74,762 in loans payable, and $149,124 in amounts due to related parties. This resulted in a loss on debt settlement of $12,460,079.